716
Views
13
CrossRef citations to date
0
Altmetric
Review

Evolution of the drug-target residence time model

Pages 1441-1451 | Received 23 Apr 2021, Accepted 24 Jun 2021, Published online: 01 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chung F. Wong. (2023) 15 Years of molecular simulation of drug-binding kinetics. Expert Opinion on Drug Discovery 18:12, pages 1333-1348.
Read now

Articles from other publishers (12)

Lilin Song, Mengru Sun, Jinhui Shi, Zhenhao Tian, Yuqing Song, Huixin Liu, Shanshan Zhao, Heng Yin & Guangbo Ge. (2023) Rational Construction of a Novel Bioluminescent Substrate for Sensing the Tumor-Associated Hydrolase Notum. Analytical Chemistry 95:13, pages 5489-5493.
Crossref
Samith Rathnayake, Brajesh Narayan, Ron Elber & Chung F. Wong. (2022) Milestoning simulation of ligand dissociation from the glycogen synthase kinase 3β. Proteins: Structure, Function, and Bioinformatics 91:2, pages 209-217.
Crossref
Carlos D. Flores-León, Luis Fernando Colorado-Pablo, Miguel Á. Santos-Contreras & Rodrigo Aguayo-Ortiz. (2023) Determination of nucleoside DOT1L inhibitors’ residence times by τRAMD simulations. Frontiers in Drug Discovery 2.
Crossref
Bharath Srinivasan, Juan Daniel Flórez Weidinger, Xiang Zhai, Guillaume Lemercier, Timothy Ikeda, Mark Brewer, Bairu Zhang, Stephan Heyse, Jonathan Wingfield & Stephan Steigele. (2022) High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery. SLAS Discovery 27:8, pages 460-470.
Crossref
Michael Miller, Thomas Rossetti, Jacob Ferreira, Lubna Ghanem, Melanie Balbach, Navpreet Kaur, Lonny R. Levin, Jochen Buck, Maria Kehr, Sandrine Coquille, Joop van den Heuvel, Clemens Steegborn, Makoto Fushimi, Efrat Finkin-Groner, Robert W. Myers, Stacia Kargman, Nigel J. Liverton, David J. Huggins & Peter T. Meinke. (2022) Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates. Journal of Medicinal Chemistry 65:22, pages 15208-15226.
Crossref
Renata R. Kazakova & Patrick Masson. (2022) Quantitative Measurements of Pharmacological and Toxicological Activity of Molecules. Chemistry 4:4, pages 1466-1474.
Crossref
Manuel F Juette, Jordan D Carelli, Emily J Rundlet, Alan Brown, Sichen Shao, Angelica Ferguson, Michael R Wasserman, Mikael Holm, Jack Taunton & Scott C Blanchard. (2022) Didemnin B and ternatin-4 differentially inhibit conformational changes in eEF1A required for aminoacyl-tRNA accommodation into mammalian ribosomes. eLife 11.
Crossref
Sabina Quader & Joachim F. R. Van Guyse. (2022) Bioresponsive Polymers for Nanomedicine—Expectations and Reality!. Polymers 14:17, pages 3659.
Crossref
Katya Ahmad, Andrea Rizzi, Riccardo Capelli, Davide Mandelli, Wenping Lyu & Paolo Carloni. (2022) Enhanced-Sampling Simulations for the Estimation of Ligand Binding Kinetics: Current Status and Perspective. Frontiers in Molecular Biosciences 9.
Crossref
Maria Russi, Gabriele Cavalieri, Domenico Marson, Erik Laurini & Sabrina Pricl. (2022) Binding of the B-Raf Inhibitors Dabrafenib and Vemurafenib to Human Serum Albumin: A Biophysical and Molecular Simulation Study. Molecular Pharmaceutics 19:5, pages 1619-1634.
Crossref
Robert A. Copeland. (2021) Chance Favors the Perplexed Mind: The Critical Role of Mechanistic Biochemistry in Drug Discovery. Biochemistry 60:29, pages 2275-2284.
Crossref
Magdalena Ługowska & Marcin Pacholczyk. (2022) PDBrt: A free database of complexes with measured drug-target residence time. F1000Research 10, pages 1236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.